Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis
De Haan, R.J.; Polman, C.H.
Nederlands Tijdschrift Voor Geneeskunde 140(44): 2168-2171
1996
ISSN/ISBN: 0028-2162 PMID: 8984352 Document Number: 459327
Document emailed within 1 workday
Related Documents
Wilson, B.A. 1995: Interferon beta for treatment of multiple sclerosis Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 4(2): 151-153Lebrun, C. 2001: Beta-interferon clinical trials using MRI in patients with multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 761-767
Cardy, P. 1997: Interferon beta in multiple sclerosis. Relapses deserve treatment Bmj 314(7080): 602
Khabirov, F.A.; Babicheva, N.N.; Khaĭbullin, T.I.; Aver'ianova, L.A.; Granatov, E.V.; Akhmedova, G.M. 2012: Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(9 Part 2): 113-122
Bencsik, K.; Rajda, C.; Klivényi, P.; Járdánházy, T.; Török, M.; Vécsei, L. 1999: Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b Orvosi Hetilap 140(14): 763-766
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Burnfield, A. 1997: Interferon beta in multiple sclerosis. Reducing frequency and severity of relapses will be of great clinical benefit Bmj 314(7080): 600
Demina, T.L.; Khachanova, N.V.; Davydovskaia, M.V. 2005: Use of beta-interferon in the treatment of multiple sclerosis: high-rate injectable dose therapy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 105(5): 76-79
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Bartholomé, E.J.; Willems, F.; Crusiaux, A.; Thielemans, K.; Schandené, L.; Goldman, M. 1999: Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis Acta Neurologica Belgica 99(1): 44-52
Niezgoda, A.; Losy, J. 2000: The effect of cladribine treatment on beta-2 microglobin in the cerebrospinal fluid and serum of patients with multiple sclerosis Neurologia i Neurochirurgia Polska 34(2): 281-287
Palao-Duarte, S.; Corral-Corral, I.; Zarza, B.; Costa-Frossard, L. 2005: Ulcerative colitis in a female patient with multiple sclerosis receiving treatment with interferon Revista de Neurologia 41(5): 319-320
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Jacobs, L.; Salazar, A.M.; Herndon, R.; Reese, P.A.; Freeman, A.; Josefowicz, R.; Cuetter, A.; Husain, F.; Smith, W.A.; Ekes, R. 1986: Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis Lancet 2(8521-22): 1411-1413
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Yoshida, M.; Ohta, M.; Muroi, K.; Takeda, K.; Kitagawa, S.; Tsuboyama, A.; Sakamoto, S.; Miura, Y.; Mutoh, Y. 1984: Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1394-1398
Milne, R.; Clegg, A.; Bryant, J. 2001: Drug treatment of multiple sclerosis. Clinical review was unsystematic Bmj 322(7281): 299